Y-mabs therapeutics shareholder alert: claimsfiler reminds investors with losses in excess of $100,000 of lead plaintiff deadline in class action lawsuit against y-mabs therapeutics, inc. - ymab

New orleans , jan. 27, 2023 /prnewswire/ -- claimsfiler, a free shareholder information service, reminds investors that they have until march 20, 2023 to file lead plaintiff applications in a securities class action lawsuit against y-mabs therapeutics, inc. (nasdaqgs: ymab), if they purchased the company's securities between october 6, 2020 and october 28, 2022, inclusive (the "class period"). this action is pending in the united states district court for the southern district of new york.
YMAB Ratings Summary
YMAB Quant Ranking